FDA acts to stem shortages of two cancer drugs

health.yahoo.net: : (Reuters) - The Food and Drug Administration is addressing the shortage of critical cancer medications by importing one drug from abroad and rushing the approval of another.



1 person shared this quote till date.

Related Articles

  • FDA Wants Prescription Drug "Vending Machines"

    articles.mercola.com
    Shared once

    The Food and Drug Administration (FDA) proposes another method to make potentially dangerous prescription drugs more readily available to people.

  • Stem cell drug approved in Canada to treat bone marrow transplant symptoms

    www.globalpost.com
    Shared once

    Canadian regulators have approved the world's first stem cell drug. The drug, Prochymal, will be used to treat a deadly side effect of bone marrow transplants called acute graft-versus host disease, which occurs in children.

  • Study identifies biomarkers that predict patients' response to certain colon cancer drugs

    www.news-medical.net
    Shared once

    The Stem Cells and Cancer Research Group headed by Dr H-ctor G. Palmer at the Vall d'Hebr-n Institute of Oncology (VHIO) has identified the molecular mechanisms that determine patients' response to certain drugs used in clinical trials for colon cancer treatment. The study led by VHIO also benefited from the collaboration with Professor Alberto Mu-oz-s laboratory at the Instituto de Investigaciones Biomedicas Alberto Sols, Consejo Superior de Investigaciones Cient-ficas.

  • Drug could boost brain cancer survival

    news.ninemsn.com.au
    Shared once

    A new drug has been found to shrink brain tumours in patients with advanced melanoma, in what has been described as a huge leap forward in treatment.

  • FDA approves Teva's generic version of blood thinner Plavix - NY Daily News

    india.nydailynews.com
    Shared 6 times

    May 20--Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA; TASE: TEVA) has obtained US Food and Drug Administration (FDA) approval for its generic version of the blood thinner Plavix (clopidogrel bisulfate). The drug helps reduce the risk of heart attack and stroke by making it less likely that platelets in the blood will clump and form clots in the arteries. Teva, Mylan Inc. (NYSE: MYL), Apotex Corporation, Roxane Laboratories Inc. of the US, India's Sun Pharmaceutical Industries Ltd. (BSE: 524

Top Links

blog comments powered by Disqus